Selected research
Industry Research
IVD CDMO Industry Research Report 2026
Market perspective
The global IVD CDMO market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the IVD CDMO market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the IVD CDMO market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the IVD CDMO market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of IVD CDMO include Hitachi, Canon, TE Connectivity, JEOL, HU Group, DCN DX, Stevanato, Argonaut and Erreka, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global IVD CDMO market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to IVD CDMO.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
IVD CDMO Market by Company
Hitachi
Canon
TE Connectivity
JEOL
HU Group
DCN DX
Stevanato
Argonaut
Erreka
GBC
Phillips Medisize
AIVD Biotech
Kaishi Biological Technology
Keysmile Biological Technology
Nabai Medical Technology
Hochuen Medical
IVD CDMO Segment by Type
Molecular Diagnosis
Immunodiagnosis
Biochemical Diagnosis
Other
IVD CDMO Segment by Application
Instruments
Consumables
IVD CDMO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVD CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IVD CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVD CDMO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of IVD CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Molecular Diagnosis
- Immunodiagnosis
- Biochemical Diagnosis
- Other
Applications
- Instruments
- Consumables
Companies covered
- Hitachi
- Canon
- TE Connectivity
- JEOL
- HU Group
- DCN DX
- Stevanato
- Argonaut
- Erreka
- GBC
- Phillips Medisize
- AIVD Biotech
- Kaishi Biological Technology
- Keysmile Biological Technology
- Nabai Medical Technology
- Hochuen Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 IVD CDMO by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Molecular Diagnosis
- 2.2.3 Immunodiagnosis
- 2.2.4 Biochemical Diagnosis
- 2.2.5 Other
- 2.3 IVD CDMO by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Instruments
- 2.3.3 Consumables
- 2.4 Assumptions and Limitations
3 IVD CDMO Breakdown Data by Type
- 3.1 Global IVD CDMO Historic Market Size by Type (2021-2026)
- 3.2 Global IVD CDMO Forecasted Market Size by Type (2027-2032)
4 IVD CDMO Breakdown Data by Application
- 4.1 Global IVD CDMO Historic Market Size by Application (2021-2026)
- 4.2 Global IVD CDMO Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global IVD CDMO Market Perspective (2021-2032)
- 5.2 Global IVD CDMO Growth Trends by Region
- 5.2.1 Global IVD CDMO Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 IVD CDMO Historic Market Size by Region (2021-2026)
- 5.2.3 IVD CDMO Forecasted Market Size by Region (2027-2032)
- 5.3 IVD CDMO Market Dynamics
- 5.3.1 IVD CDMO Industry Trends
- 5.3.2 IVD CDMO Market Drivers
- 5.3.3 IVD CDMO Market Challenges
- 5.3.4 IVD CDMO Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top IVD CDMO Players by Revenue
- 6.1.1 Global Top IVD CDMO Players by Revenue (2021-2026)
- 6.1.2 Global IVD CDMO Revenue Market Share by Players (2021-2026)
- 6.2 Global IVD CDMO Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of IVD CDMO Head Office and Area Served
- 6.4 Global IVD CDMO Players, Product Type & Application
- 6.5 Global IVD CDMO Manufacturers Established Date
- 6.6 Global IVD CDMO Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America IVD CDMO Market Size (2021-2032)
- 7.2 North America IVD CDMO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America IVD CDMO Market Size by Country (2021-2026)
- 7.4 North America IVD CDMO Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe IVD CDMO Market Size (2021-2032)
- 8.2 Europe IVD CDMO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe IVD CDMO Market Size by Country (2021-2026)
- 8.4 Europe IVD CDMO Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific IVD CDMO Market Size (2021-2032)
- 9.2 Asia-Pacific IVD CDMO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific IVD CDMO Market Size by Country (2021-2026)
- 9.4 Asia-Pacific IVD CDMO Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America IVD CDMO Market Size (2021-2032)
- 10.2 South America IVD CDMO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America IVD CDMO Market Size by Country (2021-2026)
- 10.4 South America IVD CDMO Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa IVD CDMO Market Size (2021-2032)
- 11.2 Middle East & Africa IVD CDMO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa IVD CDMO Market Size by Country (2021-2026)
- 11.4 Middle East & Africa IVD CDMO Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Hitachi
- 12.1.1 Hitachi Company Information
- 12.1.2 Hitachi Business Overview
- 12.1.3 Hitachi Revenue in IVD CDMO Business (2021-2026)
- 12.1.4 Hitachi IVD CDMO Product Portfolio
- 12.1.5 Hitachi Recent Developments
- 12.2 Canon
- 12.2.1 Canon Company Information
- 12.2.2 Canon Business Overview
- 12.2.3 Canon Revenue in IVD CDMO Business (2021-2026)
- 12.2.4 Canon IVD CDMO Product Portfolio
- 12.2.5 Canon Recent Developments
- 12.3 TE Connectivity
- 12.3.1 TE Connectivity Company Information
- 12.3.2 TE Connectivity Business Overview
- 12.3.3 TE Connectivity Revenue in IVD CDMO Business (2021-2026)
- 12.3.4 TE Connectivity IVD CDMO Product Portfolio
- 12.3.5 TE Connectivity Recent Developments
- 12.4 JEOL
- 12.4.1 JEOL Company Information
- 12.4.2 JEOL Business Overview
- 12.4.3 JEOL Revenue in IVD CDMO Business (2021-2026)
- 12.4.4 JEOL IVD CDMO Product Portfolio
- 12.4.5 JEOL Recent Developments
- 12.5 HU Group
- 12.5.1 HU Group Company Information
- 12.5.2 HU Group Business Overview
- 12.5.3 HU Group Revenue in IVD CDMO Business (2021-2026)
- 12.5.4 HU Group IVD CDMO Product Portfolio
- 12.5.5 HU Group Recent Developments
- 12.6 DCN DX
- 12.6.1 DCN DX Company Information
- 12.6.2 DCN DX Business Overview
- 12.6.3 DCN DX Revenue in IVD CDMO Business (2021-2026)
- 12.6.4 DCN DX IVD CDMO Product Portfolio
- 12.6.5 DCN DX Recent Developments
- 12.7 Stevanato
- 12.7.1 Stevanato Company Information
- 12.7.2 Stevanato Business Overview
- 12.7.3 Stevanato Revenue in IVD CDMO Business (2021-2026)
- 12.7.4 Stevanato IVD CDMO Product Portfolio
- 12.7.5 Stevanato Recent Developments
- 12.8 Argonaut
- 12.8.1 Argonaut Company Information
- 12.8.2 Argonaut Business Overview
- 12.8.3 Argonaut Revenue in IVD CDMO Business (2021-2026)
- 12.8.4 Argonaut IVD CDMO Product Portfolio
- 12.8.5 Argonaut Recent Developments
- 12.9 Erreka
- 12.9.1 Erreka Company Information
- 12.9.2 Erreka Business Overview
- 12.9.3 Erreka Revenue in IVD CDMO Business (2021-2026)
- 12.9.4 Erreka IVD CDMO Product Portfolio
- 12.9.5 Erreka Recent Developments
- 12.10 GBC
- 12.10.1 GBC Company Information
- 12.10.2 GBC Business Overview
- 12.10.3 GBC Revenue in IVD CDMO Business (2021-2026)
- 12.10.4 GBC IVD CDMO Product Portfolio
- 12.10.5 GBC Recent Developments
- 12.11 Phillips Medisize
- 12.11.1 Phillips Medisize Company Information
- 12.11.2 Phillips Medisize Business Overview
- 12.11.3 Phillips Medisize Revenue in IVD CDMO Business (2021-2026)
- 12.11.4 Phillips Medisize IVD CDMO Product Portfolio
- 12.11.5 Phillips Medisize Recent Developments
- 12.12 AIVD Biotech
- 12.12.1 AIVD Biotech Company Information
- 12.12.2 AIVD Biotech Business Overview
- 12.12.3 AIVD Biotech Revenue in IVD CDMO Business (2021-2026)
- 12.12.4 AIVD Biotech IVD CDMO Product Portfolio
- 12.12.5 AIVD Biotech Recent Developments
- 12.13 Kaishi Biological Technology
- 12.13.1 Kaishi Biological Technology Company Information
- 12.13.2 Kaishi Biological Technology Business Overview
- 12.13.3 Kaishi Biological Technology Revenue in IVD CDMO Business (2021-2026)
- 12.13.4 Kaishi Biological Technology IVD CDMO Product Portfolio
- 12.13.5 Kaishi Biological Technology Recent Developments
- 12.14 Keysmile Biological Technology
- 12.14.1 Keysmile Biological Technology Company Information
- 12.14.2 Keysmile Biological Technology Business Overview
- 12.14.3 Keysmile Biological Technology Revenue in IVD CDMO Business (2021-2026)
- 12.14.4 Keysmile Biological Technology IVD CDMO Product Portfolio
- 12.14.5 Keysmile Biological Technology Recent Developments
- 12.15 Nabai Medical Technology
- 12.15.1 Nabai Medical Technology Company Information
- 12.15.2 Nabai Medical Technology Business Overview
- 12.15.3 Nabai Medical Technology Revenue in IVD CDMO Business (2021-2026)
- 12.15.4 Nabai Medical Technology IVD CDMO Product Portfolio
- 12.15.5 Nabai Medical Technology Recent Developments
- 12.16 Hochuen Medical
- 12.16.1 Hochuen Medical Company Information
- 12.16.2 Hochuen Medical Business Overview
- 12.16.3 Hochuen Medical Revenue in IVD CDMO Business (2021-2026)
- 12.16.4 Hochuen Medical IVD CDMO Product Portfolio
- 12.16.5 Hochuen Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst